Cargando…

Correction: Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas

Detalles Bibliográficos
Autores principales:	Zhang, Qing, Liu, Fusheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683541/ https://www.ncbi.nlm.nih.gov/pubmed/33230109 http://dx.doi.org/10.1038/s41419-020-03216-z

Ejemplares similares

Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas
por: Zhang, Qing, et al.
Publicado: (2020)

Correction: The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors
por: Wang, Guosong, et al.
Publicado: (2023)

Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
por: Jiang, Shan, et al.
Publicado: (2023)

Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorly-immunogenic tumors
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
por: Suryawanshi, Yogesh R., et al.
Publicado: (2021)

Correction: IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
Publicado: (2021)

Correction: Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas
Publicado: (2021)

Correction: Resistance to Oncolytic Myxoma Virus Therapy in Nf1(−/−)/Trp53(−/−) Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon
Publicado: (2014)

Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
por: Hu, Mingming, et al.
Publicado: (2023)

Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients
por: Ouyang, Qing, et al.
Publicado: (2022)

Correction: Zika virus has oncolytic activity against glioblastoma stem cells
por: Zhu, Zhe, et al.
Publicado: (2017)

Correction: Mesenchymal stem cells and oncolytic viruses: joining forces against cancer
Publicado: (2021)

Oncolytic Viral Therapy for Glioma by Recombinant Sindbis Virus
por: Sun, Kangyixin, et al.
Publicado: (2023)

Correction to: Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
por: Keshavarz, Mohsen, et al.
Publicado: (2019)

Correction: Complex Dynamics of Virus Spread from Low Infection Multiplicities: Implications for the Spread of Oncolytic Viruses
Publicado: (2017)

Correction: Two roads for oncolytic immunotherapy development
Publicado: (2021)

Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes
por: Chouljenko, Dmitry V., et al.
Publicado: (2020)

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts
por: Geoerger, B, et al.
Publicado: (2003)

Emerging Recombinant Oncolytic Poliovirus Therapies Against Malignant Glioma: A Review
por: Dighe, Onkar R, et al.
Publicado: (2023)

Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
por: Vera, Beatriz, et al.
Publicado: (2016)

Correction: In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
Publicado: (2021)

Correction: Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies
Publicado: (2022)

Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus
por: Saini, Uksha, et al.
Publicado: (2023)

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors
por: Wang, Guosong, et al.
Publicado: (2023)

Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
por: Kiyokawa, Juri, et al.
Publicado: (2019)

Regulatory Issues: PMDA – Review of Sakigake Designation Products: Oncolytic Virus Therapy with Delytact Injection (Teserpaturev) for Malignant Glioma
por: Maruyama, Yoshiaki, et al.
Publicado: (2023)

Correction to: COVID‑19 and therapy with essential oils having antiviral, anti‑inflammatory, and immunomodulatory properties
por: Asif, Muhammad, et al.
Publicado: (2021)

Correction to: Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma
por: Shao, Naiyuan, et al.
Publicado: (2022)

Correction to: Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
por: Draganov, Dobrin D., et al.
Publicado: (2021)

Correction: Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomes
Publicado: (2022)

Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
por: Ho, Tiffany Y., et al.
Publicado: (2021)

Correction to: Advanced imaging in adult diffusely infiltrating low-grade gliomas
por: Bulakbaşı, Nail, et al.
Publicado: (2020)

Author Correction: Positron emission tomography imaging with (89)Zr-labeled anti-CD8 cys-diabody reveals CD8(+) cell infiltration during oncolytic virus therapy in a glioma murine model
por: Kasten, Benjamin B., et al.
Publicado: (2021)

Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
por: Zheng, Meijun, et al.
Publicado: (2019)

Recent advances in oncolytic virus therapy for hepatocellular carcinoma
por: Zhu, Licheng, et al.
Publicado: (2023)

Reporter Transgenes for Monitoring the Antitumor Efficacy of Recombinant Oncolytic Viruses
por: Semenova, A. V., et al.
Publicado: (2022)

Correction: A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
Publicado: (2020)

Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice
por: Auffinger, Brenda, et al.
Publicado: (2013)

Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway
por: Du, Lisha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1b340inbi8m6npjoivkg2sq1jm